The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CEPACOL SORE THROAT-COUGH lozenges. The contract has a potential value of $7,299.67 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to government agencies, primarily the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Generated 5/23/24, 9:59 AM